Dementia News and Research

Latest Dementia News and Research

Barr Pharmaceuticals confirms patent challenge of Namenda tablets

Barr Pharmaceuticals, Inc. has confirmed that its subsidiary, Barr Laboratories, Inc., has initiated a challenge of the patent listed by Forest Laboratories, Inc. in connection with its Namenda (memantine hydrochloride) tablets, 5mg and 10mg.

14 Jan 2008

Review of Memantine for Alzheimer's

In a study published this month in the Journal of Alzheimer's Disease, researchers from the University of Aberdeen report that the drug memantine, used for the treatment of Alzheimer's disease and praised as "the first and only representative of a new class of Alzheimer drugs" works in fact similar to other existing compounds, and is beneficial only in a narrow concentration range.

11 Jan 2008

New study highlights importance soluble proteins, called cytokines, in Alzheimer's

An extraordinary new scientific study, which for the first time documents marked improvement in Alzheimer's disease within minutes of administration of a therapeutic molecule, has just been published in the Journal of Neuroinflammation .

10 Jan 2008

Testosterone levels may affect men's cognitive performance

When we think about the powers of testosterone, we usually do not consider mental processes.

8 Jan 2008

Congestive heart failure leads to greater disability, nursing home admissions

Medical breakthroughs in recent decades have allowed heart attack survivors and other heart-disease patients to live longer.

8 Jan 2008

Congestive heart failure leads to greater disability among older adults

Medical breakthroughs in recent decades have allowed heart attack survivors and other heart-disease patients to live longer. But as their hearts decline into congestive heart failure, an increasing number will experience disability and the need for nursing-home care.

7 Jan 2008

Testosterone therapy and mental function in healthy older men

When we think about the powers of testosterone, we usually do not consider mental processes.

3 Jan 2008

AstraZeneca submits sNDAs for SEROQUEL XR for bipolar symptoms

AstraZeneca has announced that the company has submitted two separate supplemental New Drug Applications (sNDAs) to the U.S. Food and Drug Administration (FDA) for once-daily SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of manic episodes associated with bipolar disorder and the treatment of depressive episodes associated with bipolar disorder.

3 Jan 2008

Fish oil benefits

It's good news that we are living longer, but bad news that the longer we live, the better our odds of developing late-onset Alzheimer's disease.

28 Dec 2007

Transient neurological attacks associated with increased risk for stroke, dementia

Patients who experience symptoms described as transient neurological attacks, such as temporary amnesia or confusion, may have a higher risk for stroke and dementia, according to a study in the December 26 issue of JAMA.

28 Dec 2007

Seniors who walk regularly lower their risk for dementia

Seniors who walk regularly and also do other forms of moderate exercise are protecting themselves against a certain form of dementia.

20 Dec 2007

War veterans with brain injuries show a faster decline in cognitive functioning as they age

A study of Vietnam war veterans who suffered brain injuries during the conflict has found that the men show a faster decline in their cognitive functioning as they grow older than veterans without such injuries.

20 Dec 2007

Brain malfunction explains dehydration in elderly

As Australia faces another hot, dry summer, scientists from Melbourne's Howard Florey Institute have warned that elderly people are at risk of becoming dehydrated because their brains underestimate how much water they need to drink to rehydrate.

17 Dec 2007

Highly promising Alzheimer's and Parkinson's research

The TI Pharma project is a large-scale study into the brain material of Alzheimer's and Parkinson's patients, who gave permission to the Netherlands Brain Bank for their tissue to be used for scientific research.

17 Dec 2007

Data suggests chromium picolinate may improve cognitive function

Nutrition 21, Inc. has announced the results of a clinical study that showed daily supplementation with 1000 mcg of chromium as chromium picolinate improved cognitive function in older adults experiencing early memory decline.

14 Dec 2007

Lipids in the brain an important factor for Alzheimer's disease

As the most common form of dementia in the Western world, Alzheimer's disease carries enormous implications for our ageing society.

10 Dec 2007

Hypertension associated with risk for mild cognitive impairment

High blood pressure appears to be associated with an increased risk for mild cognitive impairment, a condition that involves difficulties with thinking and learning, according to a report in the December issue of Archives of Neurology.

10 Dec 2007

Regular exercise helps reduce the risk of Alzheimer's, depression and dementia

British researchers from Bristol University say following a regular exercise programme can significantly reduce the risk of Alzheimer's disease by as much as a third.

10 Dec 2007

Immediate relatives of patients with Parkinson's disease face increased risk of depression/anxiety disorders

Immediate relatives (brother, sister, mother, father, son or daughter) of people who have Parkinson's disease are at increased risk for developing depression and anxiety disorders, according to a new study by Mayo Clinic.

4 Dec 2007

Genetic testing for severe type of migraine may help identify new treatment options

People with a severe type of migraine in which one side of the body becomes weak should consider genetic testing, according to research that has found familial genes for this type of migraine in people who did not have family members experiencing the problem.

4 Dec 2007